Molecular and Virological Evidence of Viral Activation From Chromosomally Integrated Human Herpesvirus 6A in a Patient With X-Linked Severe Combined Immunodeficiency
Akifumi Endo(Tokyo Medical and Dental University), Shuki Mizutani, Naoki Inoue(Mukogawa Women's University), Tetsushi Yoshikawa(Fujita Health University), Kyoko Suzuki(Fujita Health University), Ken Watanabe(Sanford Burnham Prebys Medical Discovery Institute), Tomohiro Morio(Tokyo Institute of Psychiatry), Harutaka Katano(National Institute of Infectious Diseases), Tomoyo Matsubara, Tamae Ohye(Fujita Health University), Hiroki Kurahashi, Kohsuke Imai(National Defense Medical College Hospital), Norio Shimizu(Tokyo Medical and Dental University), Masatoshi Takagi(Tokyo Medical and Dental University)
Cited by 137
Related Papers
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
|Science Immunology|2021|638
Chromosomally integrated human herpesvirus 6: questions and answers
|Reviews in Medical Virology|2011|378
Classification of HHV-6A and HHV-6B as distinct viruses
|Archives of Virology|2013|366
Human Herpesvirus 6B Genome Sequence: Coding Content and Comparison with Human Herpesvirus 6A
|Journal of Virology|1999|342
ICTV Virus Taxonomy Profile: Herpesviridae 2021
|Journal of General Virology|2021|255